Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose dexamethasone plus thalidomide versus high-dose dexamethasone plus low-dose prednisone in newly diagnosed ITP
ChiCTR-IIR-17012850Phase 2Recruiting
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Oct 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of dexamethasone, thalidomide and prednisone in immune thrombocytopenia (ITP), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoint: Platelet count. Started Oct 2017; status: recruiting.
02
Drugs
dexamethasonethalidomideprednisone
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR-IIR-17012850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17012850.